187 related articles for article (PubMed ID: 35873760)
1. TGFβ1 as a Predictive Biomarker for Collateral Formation Within Ischemic Moyamoya Disease.
Chen Y; Tang M; Li H; Liu H; Wang J; Huang J
Front Neurol; 2022; 13():899470. PubMed ID: 35873760
[TBL] [Abstract][Full Text] [Related]
2. Assessment of plasma soluble Tie-2 level to distinguish moyamoya disease from atherosclerotic cerebrovascular disease and predict postoperative neovascularization.
Chen T; Wei W; Zhang J; Yu J; Xu S; Wu D; Li X; Chen J
J Neurosurg; 2023 Dec; 139(6):1705-1714. PubMed ID: 37347656
[TBL] [Abstract][Full Text] [Related]
3. Correlation Between Apelin and Collateral Circulation in Patients with Middle Cerebral Artery Occlusion and Moyamoya Disease.
Wu H; Xia C; Li R; Tao C; Tang Q; Hu W
Int J Gen Med; 2022; 15():699-709. PubMed ID: 35082519
[TBL] [Abstract][Full Text] [Related]
4. Transdural Collateral Circulation Indicates Cerebral Ischemia in Moyamoya Disease.
Chen Y; Tang M; Liang Y; Liu H; Wang J; Huang J
World Neurosurg; 2023 Aug; 176():e200-e207. PubMed ID: 37187348
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 Promoted Collateral Vessel Formation in Patients With Moyamoya Disease.
Zhao J; Yu Z; Zhang Y; Qiu C; Zhang G; Chen L; He S; Ma J
Front Neurol; 2022; 13():796339. PubMed ID: 35557625
[TBL] [Abstract][Full Text] [Related]
6. Differential Expression of Vascular Endothelial Growth Factor-A
Jiang H; Toscano JF; Schiraldi M; Song SS; Schlick KH; Dumitrascu OM; Liou R; Lyden PD; Pan J; Zhan R; Saver JL; Gonzalez NR
J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):360-368. PubMed ID: 30392834
[TBL] [Abstract][Full Text] [Related]
7. Evolution into moyamoya disease in an infant with internal carotid artery aneurysms.
Tanaka R; Takahashi S; Okano S; Okayama A; Suzuki N; Kure S; Azuma H
eNeurologicalSci; 2017 Mar; 6():80-82. PubMed ID: 29260015
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome-wide analysis of intracranial artery in patients with moyamoya disease showing upregulation of immune response, and downregulation of oxidative phosphorylation and DNA repair.
Kanamori F; Yokoyama K; Ota A; Yoshikawa K; Karnan S; Maruwaka M; Shimizu K; Ota S; Uda K; Araki Y; Okamoto S; Maesawa S; Wakabayashi T; Natsume A
Neurosurg Focus; 2021 Sep; 51(3):E3. PubMed ID: 34469870
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic development of choroidal and thalamic collaterals in hemorrhagic-onset moyamoya disease: case-control study of the Japan Adult Moyamoya Trial.
Fujimura M; Funaki T; Houkin K; Takahashi JC; Kuroda S; Tomata Y; Tominaga T; Miyamoto S
J Neurosurg; 2019 May; 130(5):1453-1459. PubMed ID: 29726780
[TBL] [Abstract][Full Text] [Related]
10. Different aspects of dysexecutive syndrome in patients with moyamoya disease and its clinical subtypes.
Fang L; Huang J; Zhang Q; Chan RC; Wang R; Wan W
J Neurosurg; 2016 Aug; 125(2):299-307. PubMed ID: 26722860
[TBL] [Abstract][Full Text] [Related]
11. Infarct Pattern and Collateral Status in Adult Moyamoya Disease: A Multimodal Magnetic Resonance Imaging Study.
Kim DY; Son JP; Yeon JY; Kim GM; Kim JS; Hong SC; Bang OY
Stroke; 2017 Jan; 48(1):111-116. PubMed ID: 27909201
[TBL] [Abstract][Full Text] [Related]
12. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
[TBL] [Abstract][Full Text] [Related]
13. Carotid ultrasonography predicts collateral development following combined direct and indirect revascularization surgery in adult ischemic Moyamoya disease.
Matsuo S; Amano T; Miyamatsu Y; Yamashita S; Yasaka M; Okada Y; Nakamizo A
Clin Neurol Neurosurg; 2021 Apr; 203():106590. PubMed ID: 33711640
[TBL] [Abstract][Full Text] [Related]
14. GM-CSF Promotes the Development of Dysfunctional Vascular Networks in Moyamoya Disease.
Li H; Cao X; Gu X; Dong M; Huang L; Mao C; Xia S; Yang H; Bao X; Yang Y; Xu Y
Neurosci Bull; 2024 Apr; 40(4):451-465. PubMed ID: 38113014
[TBL] [Abstract][Full Text] [Related]
15. Hemorrhagic Moyamoya Disease : A Recent Update.
Fujimura M; Tominaga T
J Korean Neurosurg Soc; 2019 Mar; 62(2):136-143. PubMed ID: 30428637
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease.
Rafat N; Beck GCh; Peña-Tapia PG; Schmiedek P; Vajkoczy P
Stroke; 2009 Feb; 40(2):432-8. PubMed ID: 19095988
[TBL] [Abstract][Full Text] [Related]
17. Expression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with moyamoya disease.
He J; Wang R; Zhang D; Zhang Y; Zhang Q; Zhao J
Exp Ther Med; 2014 Jul; 8(1):302-308. PubMed ID: 24944638
[TBL] [Abstract][Full Text] [Related]
18. Direct versus indirect revascularization in the treatment of moyamoya disease.
Park SE; Kim JS; Park EK; Shim KW; Kim DS
J Neurosurg; 2018 Aug; 129(2):480-489. PubMed ID: 29076784
[TBL] [Abstract][Full Text] [Related]
19. The prospects and pitfalls in the endovascular treatment of moyamoya disease-associated intracranial aneurysms.
Hou K; Li G; Luan T; Xu K; Yu J
Neurosurg Rev; 2021 Feb; 44(1):261-271. PubMed ID: 32052219
[TBL] [Abstract][Full Text] [Related]
20. Endothelial Progenitor Cells Induce Angiogenesis: a Potential Mechanism Underlying Neovascularization in Encephaloduroarteriosynangiosis.
Wang QN; Zou ZX; Wang XP; Zhang Q; Zhao YQ; Duan L; Bao XY
Transl Stroke Res; 2021 Apr; 12(2):357-365. PubMed ID: 32632776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
